Alissa Weaver

Alissa Weaver, professor of cell and developmental biology, was honored for her work on a paper published in Developmental Cell titled “VAP-A and its binding partner CERT drive biogenesis of RNA-containing extracellular vesicles at ER membrane contact sites.” Read More

Researchers from the School of Medicine Basic Sciences recently developed an analytical tool called EV Fingerprinting that could lead to the use of “liquid biopsies” as a substitute for traditional biopsies for certain patients or diseases. Read More

Manuel Ascano and Alissa Weaver are one of nine research teams to receive funding to understand the potential biotechnological uses of RNA more fully. The research is expected to provide opportunities to partner with industry to translate knowledge gained in the laboratory into marketable new therapeutics. Read More

A team of Vanderbilt engineers, biologists and education specialists have received a $3 million grant from the National Science Foundation to advance large-scale biomanufacturing of cell-derived nanoparticles that can deliver precisely targeted drugs to the site of a disease. The grant is part of the NSF’s Future Manufacturing program that is… Read More

By Selene Colon The School of Medicine Basic Sciences would like to recognize our faculty for pursuing high-impact research that leads to national recognition of Vanderbilt’s research excellence. High-impact science is often identified by the number of citations related papers receive, but highly cited papers are not always in premier… Read More

Alissa Weaver, Professor and Cornelius Vanderbilt Chair, Vanderbilt University, and Matthew Tyska, Cornelius Vanderbilt Professor, Vanderbilt University have been named 2022 ASCB Fellows. “The 2022 ASCB Fellows are individuals who have contributed broadly and significantly to the cell biology community and to the Society. We honor their scientific achievement and their… Read More